Enzyme Inhibitory and Anti-cancer Properties of Moringa peregrina

Authors

DOI:

https://doi.org/10.17533/udea.vitae.v31n1a349875

Keywords:

α-glucosidase, Carbonic Anhydrase, Thymidine Phosphorylase, Neuroblastoma, Moringa peregrina

Abstract

Background: Moringa peregrina is widely used in the traditional medicine of the Arabian Peninsula to treat various ailments, because it has many pharmacologically active components with several therapeutic effects.
Objective: This study aimed to investigate the inhibitory effect of Moringa peregrina seed ethanolic extract (MPSE) against key enzymes involved in human pathologies, such as angiogenesis (thymidine phosphorylase), diabetes (α-glucosidase), and idiopathic intracranial hypertension (carbonic anhydrase). In addition, the anticancer properties were tested against the SH-SY5Y(human neuroblastoma).
Results: MPSE extract significantly inhibited α-glucosidase, thymidine phosphorylase, and carbonic anhydrase with half-maximal inhibitory concentrations (IC50) values of 303.1 ± 1.3, 471.30 ± 0.3, and 271.30 ± 5.1 µg/mL, respectively. Furthermore, the antiproliferative effect of the MPSE was observed on the SH-SY5Y cancer cell line with IC50 values of 55.1 µg/mL.
Conclusions: MPSE has interesting inhibitory capacities against key enzymes and human neuroblastoma cancer cell line.

|Abstract
= 347 veces | PDF
= 482 veces| | HTML
= 2 veces|

Downloads

Download data is not yet available.

References

- Albaayit SFA. Enzyme inhibitory properties of Zerumbone. Pak J Agri Sci. 2021;58:1207-1209. DOI: https://doi.org/10.21162/PAKJAS/21.9759

- Rauf A, Jehan N. Natural products a as potential enzyme inhibitors from medicinal plants. Enzyme Inhib Activators. 2017;165:177. DOI: https://doi.org/10.5772/67376

- Anand U, Jacobo-Herrera N, Altemimi A, Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites. 2019;9(11):258. DOI: https://doi.org/10.3390/metabo9110258

- Albaayit SFA, Rasedee A, Noor MHM. Zerumbone-Loaded Nanostructured Lipid Carrier Gel Enhances Wound Healing in Diabetic Rats. BioMed Res Int. 2022. DOI: https://doi.org/10.1155/2022/1129297

- Humadi S, Hassan SM, Ahjel SW. A Cross-Sectional Survey of Iraqi Herbalist Practicing in the Middle Euphrates Area with Recognition of their Knowledge, Practice and Attitude (Conference Paper). Iraq Pharm Sci. 2022;31:178-187. DOI: https://doi.org/10.31351/vol31issSuppl.pp178-187

- Albaayit SFA. Evaluation of anti-methicillin resistant Staphylococcus aureus property of Clausena excavata leaves by using atomic force microscopy and flowcytometry techniques. Pak J Agri Sci. 2021;58:315-320. DOI: https://doi.org/10.21162/PAKJAS/21.921

- Shaito A, Thuan DT, Phu HT, Nguyen TH, Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH, Pintus G. Herbal medicine for cardiovascular diseases: efficacy, mechanisms, and safety. Front pharmacol. 2020;11:422. DOI: https://doi.org/10.3389/fphar.2020.00422

- Albaayit SFA, Maharjan R, Abdullah R, Noor MHM. Evaluation of antimethicillin-resistant Staphylococcus aureus property of zerumbone. J Appl Biomed. 2022;20:22-36.

- Senthilkumar A, Karuvantevida N, Rastrelli L, Kurup SS, Cheruth AJ. Traditional uses, pharmacological efficacy, and phytochemistry of Moringa peregrina (Forssk.) Fiori. A Review. Front Pharmacol. 2018;9:465. DOI: https://doi.org/10.3389/fphar.2018.00465

- Elbatran SA, Abdel-Salam OM, Abdelshfeek KA, Nazif NM, Ismail SI, Hammouda FM. Phytochemical and pharmacological investigations on Moringa peregrina (Forssk) Fiori. Nat Prod Sci. 2005;11(4):199-206. DOI: https://doi.org/ 10.32725/jab.2022.002

- El-Haddad AE, Koheil MA, El-Khalik SM, Osman S. Antihyperglycemic activity and nitrile glycosides of Moringa peregrina (Forssk.) seeds. In Fourth Euro-Mediterranean Conference of Natural Products and Drug Discovery: Back to Mother Nature (Cairo/Sharm El-Sheikh: BioNat-IV). 2002. DOI: https://doi.org/10.13140/RG.2.2.25894.93763

- Albaayit SFA, Al-Khafaji ASK, Alnaimy HS. In vitro macrophage nitric oxide and interleukin-1 beta suppression by Moringa peregrina seed. Turk J Pharm Sci. 2019;16(3):362-365. DOI: https://doi.org/ 10.4274/tjps.galenos.2018.52244

- Al-Owaisi M, Al-Hadiwi N, Khan SA. GC-MS analysis, determination of total phenolics, flavonoid content and free radical scavenging activities of various crude extracts of Moringa peregrina (Forssk.) Fiori leaves. Asian Pacific J Trop Biomed. 2014;4(12):964-970. DOI: https://doi.org/10.12980/APJTB.4.201414B295

- Asghari G, Palizban A, Bakhshaei B. Quantitative analysis of the nutritional components in leaves and seeds of the Persian Moringa peregrina (Forssk.) Fiori. Pharmacognosy Res. 2015;7(3):242. DOI: https://doi.org/10.4103/0974-8490.157968

- Afsharypuor S, Asghari G, Mohagheghzadeh A, Dehshahri S. Volatile constituents of the seed kernel and leaf of Moringa peregrina (Forssk.) Fiori, Agricolt. Cultivated in Chabahar (Iran). Iran J Pharm Sci. 2010;6(2):141-144. DOI: https://www.ijps.ir/article_2138_1bb26f237636da67948db0051e24476a.pdf

- Qaisar MN, Chaudhary BA, Sajid MU, Hussain N. Evaluation of α-glucosidase inhibitory activity of dichloromethane and methanol extracts of Croton bonplandianum Baill. Trop J Pharm Res. 2014;13(11):1833-1836. DOI: https://doi.org/ 10.4314/tjpr.v13i11.9

- Elamin YY, Rafee S, Osman N, Gately K. Thymidine phosphorylase in cancer; enemy or friend?. Cancer Microenviron. 2016; 9(1):33-43. DOI: https://doi.org/10 .1007/s12307-015-0173-y

- Gaaib JN, Jumaa MG. Expression of Carbonic Anhydrase IX (CA9) in Human Tumor Tissue of Patients with Ovarian Cancer. Iraqi journal of biotechnology. 2017;16(2):81-88. DOI: https://jige.uobaghdad.edu.iq/index.php/IJB/article/view/93/56

- Albaayit SFA, Mohammed MK. Antiangiogenic activity and ROS-mediated lung cancer cell line injury of zerumbone. J Fac Pharm Ankara. 2023;47(3). DOI: https://doi.org/10.33483/jfpau.1112778

- Albaayit SFA, Maharjan R, Abdullah R, Noor MHM. Anti-Enterococcus Faecalis, Cytotoxicity, Phytotoxicity, and Anticancer Studies on Clausena excavata Burum. f.(Rutaceae) Leaves. BioMed Res Int. 2021. DOI: https://doi.org/ 10.1155/2021/3123476

- Albaayit SFA, Khan M, Abdullah R. Zerumbone induces growth inhibition of Burkitt’s lymphoma cell line via apoptosis. Nat Volatiles Essent Oils. 2021;8(3):56-63. DOI: https://doi.org/ 10.37929/nveo.927770

- Albaayit SFA, Maharjan R, Khan M. Evaluation of Hemolysis Activity of Zerumbone on RBCs and Brine Shrimp Toxicity. Baghdad Sci J. 2021;18:65-69. DOI: https://doi.org/10.21123/bsj.2021.18.1.0065

- Albaayit SFA, Ozaslan M. Cytotoxic and urease inhibition potential of Moringa peregrina seed ethanolic extract. Int J Pharmacol. 2019;15(1):151-155. DOI: https://doi.org/ 10.3923/ijp.2019.151.155

- Maher S, Choudhary MI, Saleem F, Rasheed S, Waheed I, Halim SA, Azeem M, Abdullah IB, Froeyen M, Mirza MU, Ahmad S. Isolation of antidiabetic withanolides from Withania coagulans Dunal and their in vitro and in silico validation. Biology. 2020;9(8):197. DOI: https://doi.org/10.3390/biology9080197

- Javaid S, Saad SM, Perveen S, Khan KM, Choudhary MI. 2-Arylquinazolin-4 (3H)-ones: A novel class of thymidine phosphorylase inhibitors. Bioorg Chem. 2015;63:142-151. DOI: https://doi.org/10.1016/j.bioorg.2015.10.006

- Avula SK, Rehman NU, Khan M, Halim SA, Khan A, Rafiq K, Csuk R, Das B, Al-Harrasi A. New synthetic 1H-1, 2, 3-triazole derivatives of 3-O-acetyl-β-boswellic acid and 3-O-acetyl-11-keto-β-boswellic acid from Boswellia sacra inhibit carbonic anhydrase II in vitro. Med Chem Res. 2021;30(6):1185-1198. DOI: https://doi.org/10.1007/s00044-021-02723-8

- Hussain SS, Rafi K, Faizi S, Razzak ZA, Simjee SU. A novel, semi-synthetic diterpenoid 16 (R and S)-phenylamino-cleroda-3, 13 (14), Z-dien-15, 16 olide (PGEA-AN) inhibits the growth and cell survival of human neuroblastoma cell line SH-SY5Y by modulating P53 pathway. Mol Cell Biochem. 2018;449(1):105-115. DOI: https://doi.org/10.1007/s11010-018-3347-3

- WHO Noncommunicable Diseases. 2021. [(accessed on 31 December 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

- Cole JB, Florez JC. Florez. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2010;16(7):377-390. DOI: https://doi.org/10.1038/s41581-020-0278-5

- Sardabi F, Azizi MH, Gavlighi HA, Rashidinejad A. Potential benefits of Moringa peregrina defatted seed: Effect of processing on nutritional and anti-nutritional properties, antioxidant capacity, in vitro digestibility of protein and starch, and inhibition of α-glucosidase and α-amylase enzymes. Food Chem Adv. 2022:100034. DOI: https://doi.org/10.1016/j.focha.2022.100034

- Ullah MF, Bhat SH, Abuduhier FM. Antidiabetic Potential of Hydro‐Alcoholic Extract of M oringa Peregrina Leaves: Implication as Functional Food for Prophylactic Intervention in Prediabetic Stage. J. Food Biochem. 2015;39(4):360-367. DOI: https://doi.org/10.1111/jfbc.12140

- Şöhretoğlu D, Sari S. Flavonoids as alpha-glucosidase inhibitors: Mechanistic approaches merged with enzyme kinetics and molecular modelling. Phytochem Rev. 2010;19(5):1081-1092. https://doi.org/10.1007/s11101-019-09610-6

- Su CH, Hsu CH, Ng LT. Inhibitory potential of fatty acids on key enzymes related to type 2 diabetes. Biofactors. 2013;39(4):415-421. DOI: https://doi.org/10.1002/biof.1082

- Koheil MA, Hussein MA, Othman SM, El-Haddad A. In-vivo antioxidant activity of Moringa peregrina against STZ–induced oxidative stress in type 2 diabetic rats. Mol Clin Pharmacol. 2013;4:65-75.

- Cimmino F, Pezone L, Avitabile M, Persano L, Vitale M, Sassi M, Bresolin S, Serafin V, Zambrano N, Scaloni A, Basso G. Proteomic alterations in response to hypoxia inducible factor 2α in normoxic neuroblastoma cells. J. Proteome Res. 2016;15(10):3643-3655. DOI: https://doi.org/10.1021/acs.jproteome.6b00457

- Ameis HM, Drenckhan A, Freytag M, Izbicki JR, Supuran CT, Reinshagen K, Holland-Cunz S, Gros SJ. Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma. J Enzyme Inhib Med Chem. 2016;31(3):404-409. DOI: https://doi.org/10.3109/14756366.2015.1029471

- Garbati P, Barbieri R, Cangelosi D, Zanon C, Costa D, Eva A, Thellung S, Calderoni M, Baldini F, Tonini GP, Modesto P. MCM2 and carbonic anhydrase 9 are novel potential targets for neuroblastoma pharmacological treatment. Biomedicines. 2020;8(11):471. DOI: https://doi.org/10.3390/biomedicines8110471

- Gonçalves S, Romano A. Inhibition of angiotensin converting enzyme by Rhazya stricta, Moringa peregrina and Achillea fragrantissima, used in traditional system of medicine in Arabian Peninsula: Implication in the management of hypertension. J Med Plant Res. 2016;10(8):93-99. DOI: https://doi.org/10.5897/JMPR2015.6043

- Gonçalves S, Romano A. Inhibitory properties of phenolic compounds against enzymes linked with human diseases. Phenolic compounds-biological activity. London: Intech Open. 2017;99-118. DOI: https://doi.org/10.5772/66844

- Albaayit SFA. In vitro evaluation of anticancer activity of Moringa peregrina seeds on breast cancer cells. Eurasia J Math Sci. 2020;11:163-166. DOI: http://www.epstem.net/en/pub/issue/58065/838264

- Hazafa A, Rehman KU, Jahan N, Jabeen Z. The role of polyphenol (flavonoids) compounds in the treatment of cancer cells. Nutr Cancer. 2020;72(3):386-397. DOI: https://doi.org/10.1080/01635581.2019.1637006

- Abd Rani NZ, Husain K, Kumolosasi E. Moringa genus: a review of phytochemistry and pharmacology. Front Pharmacol. 2018;9:108. DOI: https://doi.org/10.3389/fphar.2018.00108

- Abo El-Fadl S, Osman A, Al-Zohairy AM, Dahab AA, Abo El Kheir ZA. Assessment of total phenolic, flavonoid content, antioxidant potential and hplc profile of three moringa species leaf extracts. sci J flowers Ornam Plants. 2020;7(1):53-70. DOI: https://doi.org/10.21608/sjfop.2020.91397

- Albaayit SFA, Rasedee A, Abdullah N, Abba Y. Methanolic extract of Clausena excavata promotes wound healing via antiinflammatory and anti-apoptotic activities. Asian Pac J Trop Biomed. 2020;10(5):232-238. DOI: https://doi.org/10.4103/2221-1691.281467

- Saidu NE, Valente S, Bana E, Kirsch G, Bagrel D, Montenarh M. Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells. Bioorg Med Chem. 2012;20(4): 1584-1593. DOI: https://doi.org/10.1016/j.bmc.2011.12.032

- Albaayit SFA, Khan M, Rasedee A, Noor MHM. Ethyl acetate extract of Clausena excavata induces growth inhibition of non-small-lung cancer, NCI-H460, cell line via apoptosis. J Appl Biomed. 2021;19: 40-47. DOI: https://doi.org/ 10.32725/jab.2021.007

(https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:584740-1)

Downloads

Published

05-03-2024

How to Cite

Shaymaa. (2024). Enzyme Inhibitory and Anti-cancer Properties of Moringa peregrina. Vitae, 31(1). https://doi.org/10.17533/udea.vitae.v31n1a349875

Issue

Vol. 31 No. 1 (2024)

Section

Natural Products

License

Copyright (c) 2024 Shaymaa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright Notice and Open Access Statement

The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.

Authors declare that:

  1. They are the intellectual property owners and are responsible for all the information stated in the article.

  2. This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.

  3. They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.

  4. They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.

  5. Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.

  6. They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.

  7. They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.

  8. They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.

  9. After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.

Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.

Crossref
Scopus
Google Scholar
Europe PMC